ROQRoquefort Therapeutics PLC
11.30GBp+0.44%Mkt Cap: 155539 GBpP/E: —Last update: 2026-05-27
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap155.54K GBp
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)—
Revenue/Share—
Last Price11.30 GBp
Fiscal Year End—
MR Quarter—
Employees—
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B—
EPS (TTM)—
EPS (Forward)—
52W Range
0.950036% of range30.00
52W High30.00 GBp
52W Low0.9500 GBp
Profitability
Gross Margin—
Oper. Margin—
EBITDA Margin—
Profit Margin—
ROE—
ROA—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF—
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio—
Quick Ratio—
Book Value/Sh—
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate—
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float—
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg—
Avg Vol (30d)299.61K
Avg Vol (10d)—
Technical Indicators
RSI (14)71.1
MACD0.8708
MACD Signal0.4638
MACD Hist.+0.4070
BB Upper11.91 GBp
BB Middle8.740 GBp
BB Lower5.571 GBp
BB Width72.51%
ATR (14)1.128 GBp
Vol Ratio (20d)2.63x